When it comes to managing healthcare costs, understanding your insurance coverage is crucial. If you’re considering Zepbound as a treatment option, it’s important to know whether United Healthcare (UHC) covers this medication. In this comprehensive guide, we’ll explore the coverage options for Zepbound a weight loss medication under various UHC plans, including Medicare, Medicaid, and individual plans. We’ll also delve into the different tiers of coverage and provide resources to help you navigate your prescription drug coverage.
What is Zepbound?
Brand name Zepbound is a new medication manufactured by Eli Lilly that has gained attention for its potential as a weight loss drug. It is a cutting-edge drug that has shown promising results in body weight reduction in clinical trials. The drug joins a list of six other similar prescription drugs that are FDA-approved (Food and Drug Administration). Like Novo Nordisk’s Ozempic and Wegovy, both containing the active ingredient semaglutide. It is useful to note that brand name drug Mounjaro contains the same active ingredient as Zepbound, but is FDA-approved to treat type 2 diabetes.
Zepbound targets specific mechanisms in the body to promote weight loss and contains the active ingredient tirzepatide. Zepbound activates receptors of hormones secreted from the intestine, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which reduce appetite and food intake.
Zepbound is indicated for chronic weight management in adult patients with obesity with a BMI (body mass index) of 30+, or who are overweight with a BMI of 27+ with weight-related medical health conditions. Weight-related conditions may include high blood pressure (hypertension), type 2 diabetes, obstructive sleep apnea, cardiovascular disease or high cholesterol. It is typically prescribed in conjunction with a low-calorie diet and increased physical activity to help people lose weight and maintain weight loss. The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, and injection site reactions.
Understanding Prescription Drug Lists (PDLs)
To determine whether Zepbound is covered by UHC, we need to familiarize ourselves with Prescription Drug Lists (PDLs). Also known as formularies, PDLs are lists of medications categorized into different cost levels or tiers. These tiers determine the amount you will pay for a specific medication based on your insurance plan. Each insurance provider, including UHC, has its own PDL, which outlines the coverage and costs associated with different medications.
UHC Coverage for Zepbound in Health Insurance Marketplace Plans
If you have a health plan through the Health Insurance Marketplace, also known as a State Exchange plan, it’s essential to check the PDL specific to your plan to determine the coverage and cost of Zepbound. The PDL will indicate the tier in which Zepbound falls and the corresponding cost-sharing details. To access the PDL for your plan, sign in to your account on the UHC website and navigate to the pharmacy benefits section.
UHC Coverage for Zepbound in Small and Large Group Plans
For individuals covered under UHC’s Small and Large Group plans, the PDL will determine the coverage and cost-sharing for Zepbound. It’s important to note that the PDL may vary depending on the specific plan offered by your employer. To access your plan’s PDL, sign in to your UHC account and navigate to the pharmacy benefits section. It’s recommended to review the PDL annually, as it may change from year to year.
UHC Coverage for Zepbound in Medicare Plans
If you’re enrolled in a Medicare plan through UHC, you may be wondering whether Zepbound is covered. Medicare plans typically have their own PDLs, which outline the coverage and cost-sharing for prescription medications. To determine the coverage for Zepbound under your Medicare plan, sign in to your account on the UHC Medicare website and navigate to the pharmacy benefits section. Here, you’ll find information specific to your plan, including the tier and cost-sharing details for Zepbound.
UHC Coverage for Zepbound in Medicaid Plans
Medicaid plans vary by state, so coverage for Zepbound will depend on the specific Medicaid plan you’re enrolled in. To determine the coverage and cost-sharing for Zepbound under your Medicaid plan, sign in to your account on the UHC Community Plan website and navigate to the pharmacy benefits section. Here, you’ll find information specific to your plan, including the tier and cost-sharing details for Zepbound.
Additional Resources for Understanding Coverage
Navigating prescription drug coverage can be complex, but UHC provides additional resources to help you understand your coverage options. On the UHC website, you can find comprehensive information about pharmacy programs, the Oxford pharmacy network, and frequently asked questions about pharmacy benefits. If you have specific questions about your coverage, it’s always best to reach out to UHC directly for personalized assistance.
Conclusion
Determining whether United Healthcare covers Zepbound requires a thorough understanding of your specific plan and its Prescription Drug List. By accessing your plan’s PDL and reviewing the tier and cost-sharing details for Zepbound, you can make informed decisions about your healthcare. Remember to regularly check for updates to the PDL, as coverage and cost-sharing details may change. If you have any further questions or need assistance, don’t hesitate to reach out to UHC for guidance. With a clear understanding of your coverage, you can confidently explore Zepbound as a treatment option.
Sources
About NowPatient's Editorial Process
- Written by clinical authors
- Reviewed every 2 years
- Conflicts of interest declared
NowPatient's medical content is selected by a panel of practising clinicians (pharmacists, doctors and allied healthcare professionals) and researched by an in-house team of writers who all hold scientific or clinical backgrounds. Sponsorship and conflicts of interest are openly declared.
Every article is peer-reviewed by a clinician for clinical accuracy, evidence base and accessibility, including consideration of the particular characteristics set out in the UK Equality Act 2010. Only then is it released for publication against fixed placement guidelines.
All content is cycle reviewed (typically every two years) and updated sooner if evidence, guidelines or a complaint require it. Changes follow a formal change control procedure and are reflected in the "last updated" date on each article. NowPatient is governed by MiHealth; UK pharmacy services are provided by MiHealth Pharmacy (GPhC 1036487).















































